This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference and Expo on Toxicology and Applied Pharmacology” (Toxicology 2023) Hybrid Event scheduled during June 12-13, 2023 | Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at [email protected] or call + 1 (702) 988 2320.
Regulatory agencies all over the world are advocating for less animal testing and more use of emerging alternative technologies, while also demanding more substance toxicity evaluation and characterization than ever before. Predictive toxicology is a multidisciplinary approach to chemical toxicity assessment that employs a variety of non-animal testing methods to predict a chemical's effects on biological systems. This method has several advantages over traditional hazard assessment approaches, including the elimination of the need for extensive animal experiments and their accompanying expenditures. Over the last few decades, governmental and private organisations have been rapidly increasing their use of computational methodologies for modelling pharmacological and toxicological data paired with strong data mining algorithms. The Predictive Toxicological Roadmap also outlines toxicology domains that could benefit from increased predictability, as well as promising emerging technologies that could satisfy these demands while simultaneously supporting the 3Rs for animals (Replacement, Reduction, and Refinement).
In the pharmaceutical industry, artificial intelligence refers to the use of automated algorithms to do tasks that formerly required human intelligence. Artificial intelligence has revolutionised how scientists discover new treatments, combat disease, and more in the pharmaceutical and biotech industries during the last five years. In the pharmaceutical sector, artificial intelligence and machine learning are crucial. According to industry stakeholders, the best use cases for these technologies are drug development, drug manufacturing, diagnostic aid, and enhancing medical treatment operations. By 2025, over half of all global healthcare corporations will have implemented artificial intelligence plans, according to some experts, and it will be critical for how businesses operate in the future.
Title : Countering bacterial antibiotic resistance
A C Matin, Stanford University School of Medicine, United States
Title : Functionalized PCL/PVP fibrous mats and their potential application as wound dressings
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Radio protective activity of serotonin- modulating anti consolidation protein
A.A.Mekhtiev, Academician Abdulla Garayev Institute of Physiology, Azerbaijan
Title : Vertebral primary bone lesions: When to intervene
Brandon Lucke Wold, University of Florida, United States
Title : Chemical carcinogens
Ana Faustino, University of Evora, Portugal
Title : Risk assessment of plastic additive (DEHP) on pearl spot (Etroplus suratensis)
Aniket Desai, CSIR- National Institute of Oceanography, India